Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 6NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3CNS 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 18Leukemia, Myeloid, Acute 17Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Congenital Abnormalities 10Lymphoma 8Leukemia, Myeloid, Chronic-Phase 8Neoplasms, Plasma Cell 7Multiple Myeloma 7Leukemia, Myelomonocytic, Chronic 7Neuroblastoma 6Leukemia, Myelomonocytic, Acute 6Anemia, Refractory, with Excess of Blasts 6Myeloproliferative Disorders 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Erythroblastic, Acute 5Burkitt Lymphoma 5Blast Crisis 5Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Hodgkin Disease 4Sarcoma 3

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Vincristine 6Phantoms, Imaging 6Cyclophosphamide 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Ifosfamide 5Etoposide 5Biopsy 5Temozolomide 4Radiotherapy 4Doxorubicin 4Dactinomycin 4Topotecan 3Melphalan 3Irinotecan 3Filgrastim 3Carboplatin 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2tanespimycin 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ixabepilone 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Neuroectodermal Tumors, Primitive, Peripheral × Busulfan × Clear all
NCT00020566 2014-06-24

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
1,200 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00084695 2014-01-10

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
CNSClassical hematologyLymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fanconi Anemia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Recurrence, Sarcoma, Leukemia, Myeloid, Chronic-Phase, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

NCT00112645 2013-07-18

Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
10 enrolled
CNSSarcoma

Neuroblastoma, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡